A review of biomarkers in the context of type 1 diabetes: Biological sensing for enhanced glucose control

Bioengineering & Translational Medicine

Farshad Tehrani¹  Joseph Wang¹  Hazhir Teymourian¹  Eva Vargas¹  Eleonora M. Aiello²  Kelilah L. Wolkowicz²  Francis J. Doyle²  Eyal Dassau³  Mary‐Elizabeth Patti⁴  Lori M. Laffel⁴  Jordan E. Pinsker⁵ 

[1] Department of Nanoengineering, University of California San Diego, La Jolla, California, USA;Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts, USA;Sansum Diabetes Research Institute, Santa Barbara, California, USA;Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts, USA;Sansum Diabetes Research Institute, Santa Barbara, California, USA;Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA;Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA;Sansum Diabetes Research Institute, Santa Barbara, California, USA;

关键词: automated insulin delivery;    biosensors;    measurement;    medical devices;    nanobiology;    type 1 diabetes;   

DOI  :  10.1002/btm2.10201

来源: Wiley

【 授权许可】

CC BY